223 Current news from the ressort products

rss

Roche Applied Science and TIB Molbiol offer Assay Solution for Rapid EHEC Identification

06-01-2011

With the recent outbreak in Europe of Enterohaemorrhagic Escherichia coli (EHEC), Roche Applied Science and TIB Molbiol are providing scientists with complementary technologies that can be used for the rapid identification and detection of EHEC.As of the second week of May 2011, there has ...

more

Analytik Jena Receives China's Most Prestigious Award of the Analytics Industry

05-24-2011

The new real-time PCR device qTower from Analytik Jena AG was honored as "One of the best new devices in 2010" at this year's Annual Conference of China Scientific Instruments (ACCSI). "This award is an important signal for us in the current phase of the market introduction of our real-time ...

more

Eppendorf Centrifuge 5424 R wins a ‘red dot award: product design 2011’

04-27-2011

Eppendorf AG celebrates success in a leading global design competition which attracted 4,433 entries from 1,700 companies in over 60 nations. Centrifuge 5424 R, a 24-place microcentrifuge, has been honoured for design excellence in the life science and medicine category of ‘red dot award: ...

more

FDA Approves Roche’s HPV Test for Identifying Women at Highest Risk for Cervical Cancer

04-21-2011

Roche announced that the US Food and Drug Administration (FDA) has approved the cobas HPV (Human Papillomavirus) Test which identifies women at highest risk for developing cervical cancer. This test will help physicians make early, more accurate decisions about patient care, which may prevent ...

more

mtm’s p16/Ki-67 dual immuno-staining identifies high-grade cervical disease in ASC-US and LSIL with high sensitivity and specificity

03-31-2011

mtm laboratories announced the publication of a new paper showing that dual staining for p16 and Ki-67 can pinpoint the underlying high-grade cervical disease with a high degree of sensitivity and specificity in women with ASC-US or LSIL cytology results. These are a group of patients ...

more

ExonHit Announces Successful Completion of the First Phase of EHT Dx14 Ongoing Clinical Validation

03-31-2011

ExonHit Therapeutics announced successful completion of the first phase of the validation study of EHT Dx14, a new transcriptomic signature allowing to differentiate, at molecular level, benign breast tumors from malignant ones.“These very promising first results confirm EHT Dx14 capability ...

more

Abbott's New HIV-1 Qualitative Assay Improves Testing Access in Remote Areas for Children and Adults

03-25-2011

Abbott announced that it has received CE-Mark for a new qualitative PCR-based HIV-1 test that produces highly accurate results from dried blood spot and plasma specimens. The new assay is a long-awaited diagnostic tool for health officials in African nations and other resource-limited areas ...

more

Cell Receptor Recycling Mechanism Discovery opens up New Class of Therapeutic Targets

03-25-2011

Prof. Manojkumar Puthenveedu of Carnegie Mellon University studies the mechanisms by which membrane trafficking controls and co-ordinates the complex signalling pathways in the brain. Despite the fact that almost all diseases can be traced to a defect in how cells respond to signals, little ...

more

First Patient Included in Multicenter Study to Evaluate SIRS-Lab’s Diagnostic Test for Blood-Stream Infection

03-24-2011

SIRS-Lab announced the inclusion of the first patient in a 1000-patient clinical study evaluating their molecular pathogen test VYOO. The multicenter trial, performed in 11 key centers across Germany and initiated in February 2011, will deliver data about the utility of the PCR test compared ...

more

Excellent early results in large OvPlex ovarian cancer biomarker study

11-16-2010

Stage 1 of HealthLinx Limited’smulti-centre, multi-site second study for OvPlex™ has returned excellent initial data for the two new biomarkers AGR2 and HTX010 being evaluated for accuracy in diagnosing ovarian cancer. To date, AGR2 and HTX010 data have been analysed in over 400 case and ...

more

Page 3 From 23
Subscribe to e-mail updates relating to your search

You will receive via e-mail the latest search results matching your search criteria. This service is free of charge and can be cancelled at any time.

Your browser is not current. Microsoft Internet Explorer 6.0 does not support some functions on Chemie.DE